Sun Shudong | Medicine | Best Researcher Award

Published on by China Scientist

Dr. Sun Shudong | Medicine| Best Researcher Award 

Dr. Shudong Sun is the Associate Chief Physician and Deputy Director of the Department of Burns and Wound Repair at Weifang People’s Hospital. He also serves as Deputy Director of the Weifang Burns Surgery Quality Control Center and is a Master’s Supervisor. A Senior Fellow of the European Wound Management Association (EWMA), Dr. Sun specializes in severe burn care, chronic wound treatment, and comprehensive scar management. His research focuses on burn-induced sepsis-related acute kidney injury and chronic refractory wound microenvironments. He leads multiple national and provincial research projects and holds several professional committee memberships. Dr. Sun has received numerous awards, including the Weifang Science and Technology Progress Award, and is recognized as a leading young medical talent in Shandong Province.

Dr. Sun Shudong | Shandong Second Medical University | China

Profile

🎓Education

  • Dr. Shudong Sun holds a Doctor of Medicine (MD) degree and has completed advanced specialized training in wound care. He is a Senior Fellow of the European Wound Management Association (EWMA) Advanced Wound Healing Program. His medical education and international training reflect a deep commitment to clinical excellence and academic advancement in the field of burns and wound repair.

👨‍🏫 Experience

  • Dr. Sun serves as the Associate Chief Physician and Deputy Director of the Department of Burns and Wound Repair at Weifang People’s Hospital. He also holds the role of Deputy Director of the Weifang Burns Surgery Quality Control Center. As a Master’s Supervisor, he is actively engaged in academic mentoring. Recognized as a Key Reserve Leader in Shandong Province’s Key Discipline in Burns and Plastic Surgery, Dr. Sun is a leading figure in his field. His selection for the Weifang Youth Medical Talent Support Program and recognition as an Excellent Trainee in the National Wound Healing Specialty Capability Training Program underscore his leadership and professional growth.

🤝 Awards and Recognition

  • Dr. Sun has received multiple accolades for his contributions to medicine and science. These include the Second Prize and two Third Prizes of the Weifang Science and Technology Progress Award, and the Second Prize in the Weifang Medical Science Popularization Contest. He was also named Excellent Lecturer by the Chinese Burn Surgery Association and won several case and paper competitions, such as the Excellent Case Award in the “Elite Cup” Case Competition and the Outstanding Work Award in the First National Youth Physician Burn Popular Science Competition. These honors reflect his clinical expertise, academic excellence, and dedication to public education.

💡Skills and Certifications

  • Dr. Sun has extensive clinical experience in the management of severe and critical burns, chemical and electrical injuries, and pediatric burn cases. He specializes in treating chronic refractory wounds such as radiation-induced skin injuries, diabetic foot ulcers, chronic lower limb ulcers, pressure ulcers, postoperative incision non-healing, and Fournier’s gangrene. He is also proficient in comprehensive scar management, offering early pharmaceutical interventions, sequential laser therapies, pressure treatment, and reconstructive surgery for complex hypertrophic and contracture scars across various body regions.

🔬 Research Focus

  • Dr. Sun’s research primarily focuses on the pathogenesis of acute kidney injury caused by burn-induced sepsis and the regulation of the microenvironment in chronic refractory wounds, as well as the application of innovative wound coverage materials. He leads and participates in several significant research projects, including the Shandong Medical Staff Science and Technology Innovation Plan, Shandong Natural Science Foundation, and Weifang Health Commission initiatives. His work integrates traditional Chinese medicine, modern clinical techniques, and biomedical innovation to improve outcomes in complex wound care.

🌎Conclusion

  • Dr. Shudong Sun’s combination of scientific excellence, clinical leadership, and sustained innovation makes him an outstanding candidate for the Research for Best Researcher Award. His work embodies the spirit of transformative research that leads to tangible medical breakthroughs. He is highly deserving of this recognition and sets a benchmark for future medical research professionals.

📖Publications

Title: Multi-functional nanofilms capable of angiogenesis, near-infrared-triggered anti-bacterial activity and inflammatory regulation for infected wound healing
Authors: Kun Wang, Yanqun Liu, Hui Wang, Yufang Liu, Xuelin Yang, Shudong Sun
Journal: Biomaterials Advances

Wenyan Wang | Biological Information | Best Researcher Award

Published on by China Scientist

Dr. Wenyan Wang | Biological Information | Best Researcher Award 

Wang Wenyan is a PhD student at Anhui University of Technology, specializing in Metallurgical Engineering with a focus on Metallurgical Intelligent Manufacturing. She holds a master’s degree in Control Theory and Control Engineering and a bachelor’s degree in Automation from the same university. Her research centers on artificial intelligence applications in industrial automation and defect detection. She has contributed to patents on apple leaf disease identification using convolutional neural networks and steel surface defect detection. Proficient in C programming and fluent in English (CET-6), she combines technical expertise with innovation in intelligent manufacturing.

Dr. Wenyan Wang | Anhui University of technology | China

Profile

SCOPUS ID

🎓Education

  • Wang Wenyan is currently a PhD student at Anhui University of Technology, specializing in Metallurgical Engineering with a focus on Metallurgical Intelligent Manufacturing. She pursued her master’s degree at the same university from September 2015 to June 2018 in Control Theory and Control Engineering. Her academic journey began at the Anhui University of Technology Business School, where she earned a bachelor’s degree in Automation from September 2011 to June 2015.

👨‍🏫Experience

  • Throughout her academic career, Wang Wenyan has been deeply involved in research and development, particularly in the areas of intelligent manufacturing and industrial automation. Her work integrates advanced control theories and computational techniques to enhance metallurgical processes.

🏆Awards and Recognitions

  • Wang Wenyan has contributed to groundbreaking research in the field of intelligent manufacturing, securing patents that demonstrate her innovative capabilities. She played a key role in the development of a convolutional neural network-based method for identifying apple leaf diseases, which was authorized in 2021. Additionally, she co-developed a method for detecting surface defects in steel products, balancing speed and accuracy, which is currently under examination.

💡Skills and Certifications

  • With a strong technical background, Wang Wenyan is proficient in C programming and has achieved a Level 2 certification. She also has a solid command of the English language, having passed the CET-6 exam. Her expertise lies in control engineering, artificial intelligence applications, and industrial automation.

🔬 Research Focus

  • Her research is centered on intelligent manufacturing within the metallurgical industry, particularly in the application of artificial intelligence and control systems to optimize industrial processes. She is actively engaged in developing advanced defect detection techniques and automation solutions that enhance efficiency and precision in metallurgical engineering.

🌎Conclusion

  • With her strong technical skills, research impact, and pioneering work in intelligent automation, Dr. Wang Wenyan is a highly deserving candidate for the Best Researcher Award. Her contributions hold significant promise for enhancing industrial efficiency, quality control, and smart manufacturing systems.

📖Publications

  • Prediction of colorectal cancer microsatellite instability and tumor mutational burden from histopathological images using multiple instance learning
    Authors: W. Wang, Wenyan; W. Shi, Wei; C. Nie, Chuanqi; B. Wang, Bing; J. Yang, Jialiang
    Journal: Biomedical Signal Processing and Control, 2025

  • SOKD: A Soft Optimization Knowledge Distillation Scheme for Surface Defects Identification of Hot-Rolled Strip
    Authors: W. Wang, Wenyan; Z. Ren, Zheng; C. Wang, Cheng; X. Pan, Xuejuan; B. Wang, Bing
    Journal: ISIJ International, 2025

  • Improving bearing fault diagnosis method based on the fusion of time–frequency diagram and a novel vision transformer
    Authors: J. Wang, Jingyuan; Y. Zhao, Yuan; W. Wang, Wenyan; Z. Wu, Ziheng
    Journal: Journal of Supercomputing, 2025

Dengke Bao | Tumor biology | Best Researcher Award

Published on by China Scientist

Prof. Dr. Dengke Bao | Tumor biology | Best Researcher Award 

Dengke Bao, Ph.D., is a professor, Ph.D. supervisor, and Deputy Dean at the School of Pharmacy, Henan University. He is a recipient of the Excellent Youth Fund Project of the Henan Natural Science Foundation and the 2022 China Postdoctoral Science Foundation Funding. His research focuses on mitochondria-related mechanisms in tumorigenesis, cancer progression, and immune regulation. He has published 20+ SCI-indexed papers in top journals like Oncogene and Cell Death & Disease and serves as an editorial member for Scientific Reports. His work provides new insights into tumor microenvironment remodeling and drug resistance in cancer therapy.

Prof. Dr. Dengke Bao | Henan University | China

Profile

SCOPUS ID

ORCID ID

🎓Education

  • Dengke Bao holds a Ph.D. and has established himself as a distinguished professor and Ph.D. supervisor. His academic journey has been marked by excellence, leading to his recognition as a Program for Central Plains Youth Top Talent and a recipient of multiple prestigious research grants.

👨‍🏫Experience

  • Currently serving as the Deputy Dean of the School of Pharmacy at Henan University, Dengke Bao has played a pivotal role in advancing molecular diagnostics and therapy. He is also the Deputy Director of the Henan Engineering Research Center for Molecular Diagnosis and Therapy of Esophageal Cancer and the Director of the Laboratory of Biomarkers and Liquid Biopsy in Kaifeng. His work has significantly contributed to understanding mitochondria-related mechanisms in tumorigenesis, cancer progression, and tumor immune regulation.

🏆Awards and Recognitions

  • Dengke Bao has been honored with numerous awards, including the Excellent Youth Fund Project of the Henan Natural Science Foundation and recognition as a Young Core Instructor of Henan. He was also a recipient of the 2022 China Postdoctoral Science Foundation Funding, highlighting his exceptional contributions to the field of oncology research.

💡Skills and Certifications

  • With a deep expertise in tumor biology and the tumor microenvironment, Dengke Bao specializes in investigating mitochondrial damage-associated molecular patterns (DAMPs) and their role in inflammatory responses and cancer therapy resistance. His research combines molecular biology, oncology, and immunology to uncover new therapeutic strategies for hepatocellular carcinoma (HCC) and other malignancies.

🔬 Research Focus

  • Dengke Bao’s research is centered on understanding how mitochondrial damage-associated molecular patterns influence the tumor microenvironment and immune regulation. His groundbreaking study demonstrated that sorafenib treatment in HCC induces the release of mitochondrial DNA into the tumor microenvironment, promoting M2 macrophage polarization through TLR9 activation and enhancing sorafenib resistance. His findings offer a new perspective on targeting mitochondrial DAMPs to reprogram tumor-associated macrophages, providing novel strategies to improve therapeutic efficacy and overcome drug resistance in cancer treatment.

 📚 Publications and Editorial Roles

  • Dengke Bao has authored over 20 SCI-indexed papers as a first or corresponding author in high-impact journals, including Oncogene, Journal of Experimental & Clinical Cancer Research, and Cell Death & Disease. He also serves as an editorial member for Scientific Reports, further solidifying his influence in the field of cancer research.

🌎Conclusion

  • Given his exceptional research contributions, leadership, and impact in oncology, Dengke Bao is a highly suitable nominee for the Research for Best Researcher Award. His work is not only innovative but also holds great promise for improving cancer treatment and patient outcomes, making him a deserving recipient of this prestigious recognition.

📖Publications

  • TEFM facilitates uterine corpus endometrial carcinoma progression by activating ROS-NFκB pathway

    • Authors: J. Lei, Q. Zhu, J. Guo, D. Bao, R. Guo
    • Journal: Journal of Translational Medicine, 2024

  • Tenofovir disoproxil fumarate mediates neuronal injury by inducing neurotoxicity

    • Authors: X. Yang, J. Zhang, Y. Cheng, H. Liu, D. Bao
    • Journal: European Journal of Clinical Microbiology and Infectious Diseases, 2023

  • PRRSV infection activates NLRP3 inflammasome through inducing cytosolic mitochondrial DNA stress

    • Authors: H. Li, X. Yang, Y. Song, B. Wan, D. Bao
    • Journal: Veterinary Microbiology, 2023